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Governments invest substantial resources in health in the expectation that these lead to increases in the 
length and quality of life. Technological 
and organisational advances have meant 
that population health status is now highly 
determined by the efficacy and efficiency of 
national health systems. Countries that invest 
more in health, particularly through public 
sector funding, tend to achieve better health 
outcomes1 while macro socio-economic 
factors have become relatively less important 
over time.2,3 It is self-evident that higher 
levels of health sector efficiency will produce 
greater health gains.
Data envelopment analysis (DEA) has been 
widely used to measure efficiency in the 
health sector, but this and most other frontier 
production analyses have focused on the 
performance of hospitals, health centres or 
specific services as decision-making units.4 
There are just a few examples of DEA being 
applied to measure the efficiency of semi-
autonomous sub-national health authorities 
at achieving population health outcomes.5,6 
Hospital productivity may be measured 
in terms of patient throughput or health 
interventions, but the productivity of health 
authorities should use broader measures 
consistent with their mandate to increase 
overall population health and to reduce 
inequalities in health outcomes. In many 
countries publicly funded health systems are 
decentralised or devolved to sub-national, 
geographically defined health authorities, 
although in most a governance and 
stewardship role is retained at central level. 
In Spain, for example, health sector budgets 
are controlled by the 17 Comunidades 
Autónomas; in Scotland, responsibility for 
health services rests with 14 Regional Health 
Boards; and in New Zealand (NZ) public sector 
health services are funded and provided 
(mainly) by 20 District Health Boards (DHBs). 
The presence of multiple ‘decision-making 
units’ makes it possible to compare their 
performance but there has been some 
reluctance to make comparisons of 
outcomes between geographically defined 
health authorities on the grounds that the 
populations they serve differ considerably 
in socio-economic factors such as age, 
income, education and ethnicity that 
are themselves closely related to health 
outcomes. However, whilst acknowledging 
that these factors are important determinants 
of the baseline population health status, 
they are not necessarily of great importance 
as determinants of the velocity of change in 
population health status over time. 
In this paper we first show that changes in life 
expectancy in NZ over the intercensal period 
from 2006 to 2013 were almost entirely 
unrelated to baseline socioeconomic and 
demographic factors. Rather, we posit that 
health change (specifically life expectancy 
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Abstract
Objective: Use data envelopment analysis (DEA) to measure the efficiency of New Zealand’s 
District Health Boards (DHBs) at achieving gains in Māori and European life expectancy (LE).
Methods: Using life tables for 2006 and 2013, a two-output DEA model established the 
production possibility frontier for Māori and European LE gain. Confidence limits were 
generated from a 10,000 replicate Monte Carlo simulation.
Results: Results support the use of LE change as an indicator of DHB efficiency. DHB mean 
income and education were related to initial LE but not to its rate of change. LE gains were 
unrelated to either the initial level of life expectancy or to the proportion of Māori in the 
population. DHB efficiency ranged from 79% to 100%. Efficiency was significantly correlated 
with DHB financial performance.
Conclusion: Changes in LE did not depend on the social characteristics of the DHB. The 
statistically significant association between efficiency and financial performance supports its 
use as an indicator of managerial effectiveness.
Implications for Public Health: Efficient health systems achieve better population health 
outcomes. DEA can be used to measure the relative efficiency of sub-national health 
authorities at achieving health gain and equity outcomes.
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for the purpose of this analysis) has been 
driven by changing patterns of exposure to 
risk factors, whose strength and impact on 
health outcomes has been modified by health 
sector intervention both at national and local 
level. Further, we suggest that subnational 
variation in ethnic-specific changes in life 
expectancy is partly determined by the 
efficiency with which individual DHBs have 
used need-weighted population-based 
funding to produce better health outcomes. 
We apply DEA as a widely used tool for the 
measurement of DHB efficiency.
NZ healthcare system organisation
It is important to begin by explaining some 
features that are specific to health in NZ. 
NZ has a multi-ethnic population divided 
broadly into: indigenous Māori (16% in 2013); 
Asians (12%); Pacific, who identify ethnically 
with one or other of the Pacific Islands (6%); 
and the rest (66%), who are overwhelmingly 
of European ethnicity and will be referred 
to here as European. The Māori and Pacific 
populations experience higher levels of 
deprivation and have lower life expectancies. 
Equity in health in NZ is measured mainly 
in terms of the reduction or elimination of 
health inequalities between Māori and Pacific, 
and European (sometimes grouped with 
Asians). Considerable effort has been devoted 
to ensuring that ethnicity is measured 
completely and accurately in the census and 
in other national databases, including the 
mortality collection.7 Individuals can have 
multiple ethnicities, however many analyses 
(and the population-based funding formula) 
apply a prioritisation to produce a single 
ethnicity code where Māori overrides all other 
ethnicities, Pacific overrides all but Māori, and 
Asian is recorded in priority to European.8 
District Health Boards serve populations 
ranging (in 2013) from 33,000 to 552,000. 
They receive funding on a capitation basis 
with weightings and adjustments made to 
reflect variation in expected health-service 
costs due to: difference in the age-sex 
structure of the population in each ethnic 
group and deprivation decile; rurality; 
treatment of non-resident populations (e.g. 
tourists); and unmet health needs in Māori 
and Pacific.9,10 The various cost-weights and 
adjustors mean that some DHBs receive up 
to 24% above the population average while 
others receive up to 12% less.9 
Methods
The basic data used in this analysis were 
period lifetables produced by Statistics New 
Zealand for each ethnic group in each DHB 
using data from the 2006 and 2013 censuses 
in combination with mortality data from the 
periods 2005-07 and 2012-14. 
The life tables were produced using a 
hierarchical Bayes model that copes with 
sparse data by sharing information across 
estimates, avoiding the need for manual 
smoothing. The methods yield explicit 
measures of uncertainty which are reflected 
in the 95% credibility limits provided 
with each table. A full description of the 
methods is provided by Statistics NZ.11 We 
derived the change in Māori and European 
life expectancy for each DHB from these 
lifetables.
The first step in the analysis involved 
testing the hypothesis that the change 
in life expectancy in each DHB between 
2006 and 2013 was unrelated to their 
baseline socioeconomic and demographic 
characteristics, and to the change in these 
over this period. Accordingly, the correlation 
between a wide variety of published 
indicators from the 2006 census and the 
change in DHB life expectancy was calculated 
and tested for statistical significance.
The second step of the analysis used output-
oriented data envelopment analysis under 
the assumption of constant returns to scale 
to estimate the efficiency of each DHB at 
producing life expectancy gains in their 
Māori and European populations. With this 
tool we are effectively considering each DHB 
as a production unit whose main outputs 
are gains in population life expectancy. We 
restricted the analysis to Māori and European 
populations to avoid intractable complexity 
in the analysis. The implications of this 
restriction are addressed in the discussion. 
The intercensal change in life expectancy 
at birth (LE) was chosen as the outcome 
of interest because it is a paramount goal 
of investment in healthcare, and as we 
demonstrate, it is largely unrelated to 
socioeconomic factors. It can be plausibly 
assumed to be attributable in a large part 
to investments in health where these are 
taken in a broad sense to include measures 
to modify risk factors and promote healthy 
lifestyles. The change in LE has the additional 
advantage that as an output, it exhibits 
constant returns to scale. This is evident 
from the fact that population LE is generally 
unrelated to the size of a country (the 
correlation coefficient for the association 
between population size and life expectancy 
at birth in 2010 for 188 countries listed on 
the Gapminder website is 0.02),12 and here 
we test the possibility at a smaller scale by 
measuring its correlation with the size of the 
DHB. LE gains have the additional advantage 
that they are intuitively understood by both 
health sector managers and the general 
population. However, a more sophisticated 
analysis would also take into account health-
related quality of life gains. 
It was assumed that each DHB received 
equal inputs with which to increase LE. As 
noted above, the population-based funding 
formula (PBFF) is designed to compensate 
each DHB equitably for differences in costs to 
serve their respective populations. In a sense, 
the PBFF can be seen as a way of ensuring 
‘equality’ of purchasing power among DHBs. 
The assumption that PBFF achieves equality 
in inputs among the DHBs was tested post 
hoc by examining whether there was any 
correlation between the calculated DHB 
efficiency scores and several factors related 
to healthcare costs that may or may not 
have been adequately adjusted for by the 
PBFF. These were: actual per capita DHB 
funding; the size of the DHB population; the 
proportion of Māori in the DHB population; 
the proportion of the population aged 85 and 
over; and DHB ‘rurality’ based on an indicator 
in recent review of the PBFF rural adjuster.13 
The efficiency scores of DHBs with tertiary 
services were also compared with those of 
DHBs without tertiary services to test that the 
PBFF adjusts adequately for this factor. If the 
PBFF has failed to adequately compensate 
for higher costs, then one might expect to 
see a negative correlation between actual per 
capita funding received and DHB efficiency. 
Conversely, if the PBFF overcompensates for 
cost differences then one might expect to 
see a positive correlation between the actual 
per capita funding and efficiency. Similarly, 
any significant correlation between the other 
variables and efficiency estimates would 
suggest that the assumption of equal health 
purchasing power may have been violated.
DEA estimates of efficiency were calculated 
using Stata and Excel. DEA is a widely used 
non-parametric method for assessing the 
efficiency of productive units and estimating 
production possibility frontiers. Although 
it does not rely on prior assumptions about 
the nature of the productive process, noise 
in measurement is known to bias efficiency 
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estimates.14 Kao and Liu have shown that if 
external estimates of measurement precision 
are available then Monte Carlo simulation 
methods can be used to produce unbiased 
‘stochastic’ efficiency estimates.14 A recent 
review of methods to perform DEA in the 
presence of measurement uncertainty 
recommended using Monte Carlo simulations 
where feasible.15
In this case we used the 95% credibility 
limits on the life table measures provided by 
Statistics New Zealand to simulate 10,000 
replications of each DHB’s gain in Māori and 
European life expectancy (assuming a normal 
distribution of the error in life expectancy 
estimates in each census year), thereby 
producing 10,000 estimates of efficiency 
along with 95% percentile limits for each 
DHB. Given their asymmetric distribution, 
median efficiency values were reported. 
Data on DHB financial deficits/supluses were 
drawn from the 2012/13 Annual Report of the 
Controller and Auditor-General.16 
Excel was used to calculate correlation 
coefficients. Stata 13 was used to perform 
a t-test (unequal variance) of the difference 
in mean efficiency scores for DHBs with and 
without tertiary level hospitals.
Results
Table 1 shows the Māori and European life 
table estimates of life expectancy for each 
DHB, and the change in these between 
2006 and 2013. Life expectancy has clearly 
improved for both European and Māori in 
all DHBs, but at a greater rate for the latter. 
The change of life expectancy among Māori 
from 2006 to 2013 was unrelated to the 
proportion of Māori in the DHB in 2006 
(correlation coefficient r=-0.16; p=0.49). The 
change in Māori life expectancy was also not 
significantly associated with the starting LE in 
2006 (r=0.19; p=0.42), suggesting that change 
was not limited at the upper end of the range. 
This was also true for Europeans (r=0.31; 
p=0.19).
Table 2 presents the correlation with LE in 
2006 and the change by 2013 for a range 
of socioeconomic variables measured at 
DHB level. Although most of the indicators 
were significantly associated with the 
level of life expectancy in 2006, none of 
them was significantly associated with the 
improvement in life expectancy over the 
subsequent seven years.
A geometrical depiction of the classical DEA 
efficiency analysis is provided in Figure 1 
where each DHB is represented as a point 
on the graph corresponding to its gain in 
LE from 2006 to 2013 for Māori (vertical 
axis) and Europeans (horizontal axis). The 
line enveloping the DHBs at the outer edge 
represents the (non-stochastic) production 
possibility frontier for these two outputs. The 
four DHBs sitting on and defining the PPF 
(Waikato, Counties Manukau, Hawkes Bay 
and Nelson Marlborough) have efficiencies 
of 100%. For the others, their efficiency can 
be represented graphically as the ratio of 
their distance from the origin to the distance 
from the origin to the PPF (passing through 
that point). So, in the case of Lakes DHB, the 
efficiency is the length of line OA divided by 
the length of line OB as shown in Figure 1.
The efficiency of each DHB calculated in this 
way is shown in Table 3. Table 3 also shows 
the median efficiency of each DHB derived 
from the Monte Carlo simulation, which 
effectively creates 10,000 different PPFs and 
calculates the DHBs’ efficiency for each of 
them. A 95 percentile confidence limit is 
provided for each Monte Carlo efficiency 
estimate. It can be seen from Table 3 that 
the Monte Carlo efficiency estimates are 
consistently equal to, or smaller than, the 
non-stochastic DEA estimates. This is because 
deterministic DEA is known to overestimate 
efficiency when there is measurement error 
or noise.17 
The median efficiency in Table 3 was found 
to be positively correlated with the size of 
the financial surplus in 2012/13 (r=0.46; 
p=0.0498), with Canterbury excluded because 
its surplus/deficit was not reported (given 
that insurance receipts from earthquake 
damages made it incomparable). More 
than half the DHBs were apparently able to 
improve their LE comfortably within their 
PBFF allocations. Conversely, DHBs with 
deficits had lower efficiency scores. Efficiency 
scores were not significantly correlated with 
the funding to population ratio (r=0.06; 
p=0.81); the size of the DHB (r=0.05; p=0.85); 
the Māori proportion of its population 
Table 1: Life expectancy at birth for Māori and European in 2006 and 2013 by DHB (with 95% credibility limits).
District Health Board
Māori European
2006* 2013* Change 2006 2013 Change
Auckland 77.1 (76.0-78.1) 79.4 (78.3-80.5) 2.3 83.5 (83.2-83.7) 84.5 (84.3-84.7) 1.0
Bay of Plenty 72.5 (71.8-73.2) 74.9 (74.2-75.6) 2.4 82.0 (81.7-82.2) 83.1 (82.9-83.4) 1.1
Canterbury 76.5 (75.5-77.7) 78.7 (77.6-79.9) 2.2 81.0 (80.8-81.2) 81.9 (81.8-82.1) 0.9
Capital and Coast 75.9 (74.8-77.1) 78.1 (77.0-79.3) 2.2 81.8 (81.5-82.1) 82.8 (82.5-83.0) 1.0
Counties Manukau 72.5 (71.8-73.2) 74.7 (74.1-75.4) 2.3 82.5 (82.2-82.7) 83.7 (83.4-83.9) 1.2
Hawke’s Bay 71.2 (70.4-72.1) 73.9 (73.1-74.7) 2.7 80.8 (80.5-81.1) 81.9 (81.7-82.2) 1.2
Hutt 73.8 (72.6-75.0) 76.2 (75.0-77.4) 2.4 80.9 (80.5-81.2) 81.9 (81.5-82.2) 1.0
Lakes 71.6 (70.8-72.5) 73.6 (72.8-74.4) 2.0 80.8 (80.4-81.2) 81.8 (81.5-82.2) 1.0
Midcentral 73.5 (72.5-74.5) 75.7 (74.8-76.7) 2.2 80.7 (80.4-80.9) 81.8 (81.5-82.1) 1.1
Nelson Marlborough 77.7 (76.0-79.6) 80.3 (78.5-82.3) 2.6 81.0 (80.7-81.3) 82.2 (81.9-82.5) 1.2
Northland 71.2 (70.5-71.9) 73.5 (72.8-74.1) 2.3 81.6 (81.3-81.9) 82.6 (82.3-82.9) 1.0
South Canterbury 77.7 (74.9-81.0) 80.0 (77.2-83.6) 2.4 80.5 (80.1-80.9) 81.4 (81.0-81.8) 0.9
Southern 76.1 (74.9-77.2) 78.4 (77.2-79.6) 2.3 80.4 (80.2-80.6) 81.3 (81.1-81.5) 0.9
Tairawhiti 70.3 (69.4-71.2) 72.6 (71.7-73.5) 2.3 80.7 (80.1-81.3) 81.8 (81.3-82.4) 1.1
Taranaki 73.5 (72.4-74.8) 75.9 (74.7-77.1) 2.4 80.6 (80.3-81.0) 81.7 (81.4-82.1) 1.1
Waikato 72.3 (71.6-72.9) 74.4 (73.8-75.0) 2.1 81.0 (80.8-81.3) 82.3 (82.1-82.5) 1.2
Wairarapa 72.0 (70.3-73.8) 74.2 (72.5-76.0) 2.2 80.5 (80.0-81.0) 81.5 (81.0-81.9) 1.0
Waitemata 77.7 (76.7-78.6) 80.1 (79.1-81.1) 2.5 84.4 (84.2-84.6) 85.5 (85.3-85.7) 1.1
West Coast 75.3 (72.8-78.0) 77.6 (75.2-80.6) 2.4 79.9 (79.4-80.4) 80.9 (80.4-81.4) 1.0
Whanganui 71.0 (69.9-72.1) 73.4 (72.3-74.6) 2.5 80.5 (80.2-80.9) 81.6 (81.2-82.0) 1.0
Source: Statistics NZ
* Statistics NZ uses the period 2005-7 and 2012-4 since mortality data was used from that range of dates. For simplicity we use the year of the census which 
provided the population base for the life tables.
Table 2: Correlation of DHB socioeconomic indicators 
with LE in 2006 and the change in LE, 2006 to 2013.







in LE  
(2006-13)
No educational qualification -0.79*** 0.08




Household income <$30,000 -0.70*** -0.06
Rental accommodation 0.26 0.26
Internet access 0.88*** -0.10
No motor vehicle -0.15 -0.34
Age-standardised smoking rate -0.89*** 0.14
Rural residence -0.55* -0.06
* p<0.05 ** p<0.01 *** p<0.001
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(r=0.20; p=0.40); the proportion of its 
population aged 85 or over (r=-0.13; p=0.59); 
nor the rurality of the population it serves  
(r=-0.06; p=0.81). Although the mean 
efficiency of DHBs with a tertiary hospital was 
lower than DHBs without one (86.2% versus 
90.6%) the difference was not statistically 
significant (p=0.23).
Discussion
This study has found reasonably high 
levels of efficiency in NZ DHBs. By means of 
comparison, Tigga and Mishra’s DEA study of 
inter-state health outcomes in India found 
a mean technical efficiency score of 84%.6 
On the other hand, in a DEA comparison of 
health system efficiency in OECD countries 
all 28 countries studied were found to 
have efficiencies of 90% and over for life 
expectancy at birth and at 65 years (but it did 
not examine change in life expectancy and 
NZ was not one of the included countries).18 
The 95% confidence limits for DHB efficiency 
all overlapped at some point, but that does 
not exclude the possibility there are in 
fact significant differences between them. 
Canterbury DHB had the lowest efficiency. 
Canterbury’s efficiency was probably affected 
by the health impact and disruptive effects 
on service delivery of the 2011 earthquake. 
Capital and Coast also had a low efficiency 
score. It is notable that this DHB had four 
different Chief Executive Officers over 
the intercensal period, each attempting 
unsuccessfully to tackle its chronic budget 
deficit, perhaps to the detriment of 
population health outcomes. If the presence 
of a budget deficit is considered to be an 
indicator of managerial effectiveness, then 
the significant correlation between efficiency 
estimates and financial deficits/surpluses 
provides support for the validity of the 
efficiency estimates that we have calculated. 
Indeed, if the deficit were incorporated 
into the input measure (DHBs that run a 
deficit effectively receive greater inputs than 
the PBFF allocation), then the correlation 
between efficiency and financial results 
would have been even stronger (data not 
shown). 
The generally high level of efficiency for 
all DHBs may reflect a relatively uniform 
standard of health sector management, but 
it could also be because policy directions and 
service guidelines provided by the Ministry 
of Health allow little scope for any particular 
DHB to shine over the rest, or because 
improvements in health outcomes are largely 
determined by national historical trends (such 
as the decline in smoking and the obesity 
epidemic), that affect all DHBs similarly, even 
if their starting levels of LE are quite different.
An obvious limitation of this study was its 
omission of Asian and Pacific life expectancy 
gains as outputs. Although DEA can readily 
cope with more than two outputs, the Monte 
Carlo simulation would have been far more 
difficult to conduct and its discriminatory 
power would have been reduced. Also, the 
Asian life tables are not subdivided into South 
Asians (predominantly of Indian, Sri Lankan, 
and Pakistani descent) and East Asians 
(mainly ethnic Chinese and Korean), whose 
distribution differs across DHBs and whose 
LE gains may also have differed considerably. 
Furthermore, Pacific and Asian populations 
in some DHBs are very low. Incorporating 
health-related quality of life measures into 
the outputs (perhaps as health expectancies) 
would be valuable in any future such 
analyses.
The approach used assumed that each DHB 
received equal levels of input based on the 
PBFF formula. Our tests of the validity of this 
assumption failed to identify any obvious 
violation and hence the observed differences 
in efficiency scores are unlikely to be due to 
differences in DHB funding.
In output-oriented DEA with two or more 
outputs the slope of the production 
possibility frontier defines opportunity costs 
and how these vary as life expectancy gains 
approach the maxima. In the flat and vertical 
segments there are no opportunity costs. 
A non-zero and non-infinite slope within 
Figure 1: Gain in Maori and European life expectancy by DHB 2006 to 2013.
Table 3: Efficiency of District Health Boards at 










Auckland 86 86 (77–96)
Bay of Plenty 96 94 (86–100)
Canterbury 82 79 (71–93)
Capital and Coast 83 83 (74–94)
Counties Manukau 100 98 (90–100)
Hawke’s Bay 100 100 (90–100)
Hutt 90 87 (76–100)
Lakes 86 84 (74–95)
Midcentral 93 92 (83–100)
Nelson Marlborough 100 100 (90–100)
Northland 86 86 (77–94)
South Canterbury 89 85 (67–100)
Southern 87 83 (74–99)
Tairawhiti 93 92 (79–100)
Taranaki 92 91 (82–100)
Waikato 100 98 (90–100)
Wairarapa 83 83 (70–100)
Waitemata 93 92 (84–100)
West Coast 89 88 (70–100)
Whanganui 91 89 (78–100)
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this frontier implies opportunity costs such 
that gains for one ethnic group can only 
be attained at the expense of gains for the 
other ethnic group. One might challenge 
this feature of DEA on the grounds that it 
should always be possible to increase Māori 
life expectancy without sacrificing European 
life expectancy (and vice versa). There are 
many health interventions which increase 
both Māori and European life expectancy 
(e.g. water chlorination). However, many 
interventions have disproportionate life 
expectancy gains for one or other ethnicity: 
for example, rheumatic fever programmes; 
melanoma treatment; housing insulation 
subsidies; bowel screening; smoking 
cessation; hepatitis treatment, aortic 
aneurysm screening, etc. The actions of health 
service planners in having to make choices 
between these interventions demonstrates 
the very real opportunity costs to one 
ethnicity of making greater life expectancy 
gains for another.
By assessing efficiency in terms of Māori 
and European LE gains it was hoped that 
it would be possible to judge the extent to 
which DHBs are pursuing greater equity 
as well as overall population health gain, 
since both are fundamental health sector 
goals. DHBs operating at 100% efficiency 
can achieve different levels of LE gain for 
Māori and Europeans. Those achieving 
higher Māori LE gains could be considered 
to be pursuing higher degrees of equity. For 
example, although Hawkes Bay and Nelson 
Marlborough DHBs were both 100% efficient, 
the former achieved a LE gain for Māori of 
2.68 compared with 2.60 for the latter. The 
opportunity cost of the 0.08-year greater 
gain in Māori life expectancy was a 0.02-year 
lower gain in European LE (1.17 versus 1.19). 
However, Māori make up 24.1% of Hawkes 
Bay’s population but only 8.9% of Nelson 
Marlborough’s. Thus the higher LE gain in 
Hawkes Bay will have a much higher impact 
on the actual number of years of life gained 
in Hawkes Bay than a similar gain for Māori 
would have had in Nelson Marlborough. 
Hence for any given DHB’s mix of Māori and 
European population, there is probably only 
one point on the PPF that maximises total 
expected years of life gained.
To our knowledge this is the first study to 
formally quantify the efficiency of NZ’s DHBs 
in achieving life expectancy gains. It has also 
demonstrated the feasibility of Monte Carlo 
based stochastic DEA. Future analyses could 
extend this work to incorporate health-
related quality of life measures and other 
ethnic groups.
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